Advanced Regenerative Manufacturing Institute
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education & workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.
Industries
Nr. of Employees
small (1-50)
Advanced Regenerative Manufacturing Institute
THE TECHNOLOGY CENTER | 400 COMMERCIAL STREET, MANCHESTER, NH, 03101
Products
Deep Tissue Characterization Center (DTCC)
A laboratory and service capability focused on identifying critical product quality attributes and developing analytical methods to support manufacturing and regulatory submissions.
Tissue Foundry automation platform
A foundry-style platform for automating and scaling biofabrication workflows, including modular automation for scaffold seeding, culture and processing.
Deep Tissue Characterization Center (DTCC)
A laboratory and service capability focused on identifying critical product quality attributes and developing analytical methods to support manufacturing and regulatory submissions.
Tissue Foundry automation platform
A foundry-style platform for automating and scaling biofabrication workflows, including modular automation for scaffold seeding, culture and processing.
Services
Process gap analysis, simplification, optimization and transition to automated workflows for tissue and cell manufacturing.
Manufacture of clinical trial material under phase-appropriate quality-management systems for cells, tissues and organs.
Analytical services to define critical product attributes, develop potency/purity/identity assays, and support QbD-based control strategies.
Consulting on preclinical study design, regulatory strategy and preparation/support for regulatory agency interactions.
Design, testing and qualification services for modular automated and closed culture and processing systems tailored to product requirements.
Development of preservation methods and temperature-controlled logistics strategies for in-process and final products.
Process gap analysis, simplification, optimization and transition to automated workflows for tissue and cell manufacturing.
Manufacture of clinical trial material under phase-appropriate quality-management systems for cells, tissues and organs.
Analytical services to define critical product attributes, develop potency/purity/identity assays, and support QbD-based control strategies.
Consulting on preclinical study design, regulatory strategy and preparation/support for regulatory agency interactions.
Design, testing and qualification services for modular automated and closed culture and processing systems tailored to product requirements.
Development of preservation methods and temperature-controlled logistics strategies for in-process and final products.
Expertise Areas
- Regenerative manufacturing
- Process development and scale-up
- Clinical manufacturing for early-phase trials
- Analytical characterization and assay development
Key Technologies
- Bioprinting and bioinks
- Closed automated cell culture platforms
- Scalable bioprocess equipment
- Tissue foundry automation platforms
News & Updates
Discover the future of defense manufacturing with ARMI | BioFabUSA at the Defense Manufacturing Conference (DMC).
The first-ever ROADMAP Summit hosted by the U.S. National Science Foundation (NSF), in partnership with the U.S. Economic Development Administration (EDA).
A webinar discussing the critical role of standards in advancing bioprinting technologies.
Join BioFabUSA at the upcoming events to explore strategies for enhancing America's manufacturing capabilities.
This article discusses the funding awarded to enhance biofabrication capabilities in New Hampshire.
Details about a grant secured by ARMI to support biofabrication research.
Discover the future of defense manufacturing with ARMI | BioFabUSA at the Defense Manufacturing Conference (DMC).
The first-ever ROADMAP Summit hosted by the U.S. National Science Foundation (NSF), in partnership with the U.S. Economic Development Administration (EDA).
A webinar discussing the critical role of standards in advancing bioprinting technologies.
Join BioFabUSA at the upcoming events to explore strategies for enhancing America's manufacturing capabilities.
This article discusses the funding awarded to enhance biofabrication capabilities in New Hampshire.
Details about a grant secured by ARMI to support biofabrication research.